Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis

Medical Mycology

Volumn 48, Issue O1, 2010, Pages

  Harun, Azian ^a,b   Gilgado, Felix ^a   Chen, Sharon C A ^a   Meyer, Wieland ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

environmental isolation; Scedosporium; Scedosporium aurantiacum; soil sampling

Indexed keywords

AIRWAY; ARTICLE; ASCOMYCETES; AUSTRALIA; CYSTIC FIBROSIS; FUNGAL COLONIZATION; FUNGAL STRAIN; MICROSPORUM CANIS; NONHUMAN; PETRIELLIDIUM BOYDII; POPULATION ABUNDANCE; PREVALENCE; PSEUDALLESCHERIASIS; QUALITATIVE ANALYSIS; RURAL AREA; SCEDOSPORIUM; SOIL ANALYSIS; URBAN AREA;

AUSTRALIA; CARRIER STATE; CITIES; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; DNA, FUNGAL; HUMANS; MYCETOMA; MYCOSES; PSEUDALLESCHERIA; RESPIRATORY SYSTEM; SCEDOSPORIUM; SEQUENCE ANALYSIS, DNA; SOIL MICROBIOLOGY;

SCEDOSPORIUM; SCEDOSPORIUM AURANTIACUM; SCEDOSPORIUM PROLIFICANS;

EID: 78649970951     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.515254     Document Type: Article

References (27)

1. Lamaris GA, Chamilos G, Lewis GRE, et al. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989 - 2006. Clin Infect Dis 2006; 43: 1580-1584.
2. Steinbach WJ, Perfect JR. Scedosporium species infections and treatments. J Chemother 2003; 15: 16-27.
3. Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21: 157-197.
4. Delhaes L, Harun A, Chen SCA, et al. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Emerg Infect Dis 2008; 14: 282-290.
5. Heath C, Slavin MA, Sorrell TC. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect 2009; 15: 689-693.
6. Cimon, B, Carrere J, Vinatier JF, et al. Clinical signif cance of Sce-dosporium apiospermum in patients with cysticf brosis. Eur J Clin Microbiol Infect Dis 2000; 19: 53-56.
7. Horre R, Marklein G. Isolation and clinical signif cance of Pseudal-lescheria and Scedosporium species. Med Mycol 2009; 47: 415-421.
8. Blyth CC, Middleton PG, Harun A, et al. Clinical associations and prevalence of Scedosporium s pp. in Australian cysticf brosis patients: identif cation of novel risk factors? Med Mycol 2010; 48(Online Suppl. 1): S37-S44.
9. Rodriguez-Tudela JL, Berenguer J, Guarro J, et al. Epidemiology and outcome of Scedosporium prolif cans infection, a review of 162 cases. Med Mycol 2009; 47: 359-370.
10. Sidot C, Simon P, Bouchara JP et al. Scedosporium apiospermum. Environmental studying the homes of patients with cysti cf brosis. J Cyst Fibros 2007; 6: S29.
11. Kaltseis J, Rainer J, de Hoog GS. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med Mycol 2009; 47: 398-405.
12. Guarro, J, Kantarcioglu AS, Horre R, et al. Scedosporium apiosper-mum : changing clinical spectrum of a therapy-refractory opportunist. Med Mycol 2006; 44: 295-327.
13. de Hoog GS, Marvin-Sikkema FD, Lahpoor GA, et al. Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolif cans. Mycoses 1994; 37: 223-224.
14. Davies JS, Wellman A, Zajic JE. Hyphomycetes utilizing natural gas. Can J Microbiol 1973; 19: 81-85.
15. Garcia Pena EI, Hernandez S, Favela-Torres E, Auria R, Revah S. Toluene biof ltration by the fungus Scedosporium apiospermum. Biotechnol Bioeng 2001; 76: 61-69.
16. Potin O, Raf n C, Veignie E. Bioremediation of aged polycyclic aromatic hydrocarbons (PAHs)-contaminated soil byf lamentous fungi isolated from soil. Int Biodeterior Biodegradation 2004; 54: 45-52. (Pubitemid 38498085)
17. Ulf g K. Factors inf uencing the occurrence of Pseudallescheria boydii in sewage sludge. 10th ECMM Congress 17 - 20 June 2004, Wroclaw, Poland.
18. Cooley L, Spelman D, Thursky K, Slavin MA. Infections with Sce-dosporium apiospermum and Scedosporium prolif cans in Australia. Emerg Infect Dis 2007; 13: 1170-1177.
19. Gilgado F, Cano J, Gene J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005; 43: 4930-4942.
20. De Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi, 2nd edn. Utrecht: Centraalbureau voor Schimmelcultures, 2000.
21. Meyer W, Maszewska K,Amirmostof an M, et al. Molecular typing of global isolates of Cryptococcusneoformans var. neoformans by PCR-f ngerprinting and RAPD - a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 1999; 20: 1790-1799.
22. Gilgado F, Cano J, Gen é J, Sutton DA, Guarro J. Molecular and phenop-typic data supporting species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedospo-rium dehoogii. J Clin Microbiol 2008; 46: 766-771.
23. Rainer J, Kaltseis J, De Hoog SG, Summerbell RC. Effcacy of a selective isolation procedure for members of the Pseudallescheria boydii complex. Antonie Van Leewenhoek 2008; 93: 315-322.
24. Tintelnot K, Antweiler E, Altmann W, Pohl W, Seibold M. Keeping an eye on environmental sources for Scedosporium species. 1st Meeting of the ISHAM Working Group on ' Fungal Respiratory Infections in Cystic Fibrosis ', 7 - 8 June 2009, Angers, France.
25. Medrela-Kuder E. Seasonal variations in the occurrence of culturable airborne fungi in outdoor and indoor air in Cracow. Int Biodeterior Biodegradation 2003; 52: 203-205.
26. Larsen L, Gravesen S. Seasonal variations of outdoor airborne viable microfungi in Copenhagen, Denmark. Grana 1991; 30: 467-471.
27. Lake FR, Tribe AE, McAleer R, Froudist J, Thompson PJ. Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boy-dii and Aspergillus. Thorax 1990; 45: 489-492.